In light of safety profiles of SGLT-2 inhibitors among kidney transplant recipients with DM, the incidence of urinary tract infection was 43.8% in our study vs. 38.0% among general kidney transplant recipients [67], which was not significantly different (p = 0.13). Here, SLC5A2 is linked to diabetes mellitus.